Xiaofang Chen

1.5k total citations
67 papers, 1.2k citations indexed

About

Xiaofang Chen is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Xiaofang Chen has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in Xiaofang Chen's work include Cancer therapeutics and mechanisms (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Heat shock proteins research (4 papers). Xiaofang Chen is often cited by papers focused on Cancer therapeutics and mechanisms (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Heat shock proteins research (4 papers). Xiaofang Chen collaborates with scholars based in China, United States and Australia. Xiaofang Chen's co-authors include Christopher C.W. Hughes, Steven C. George, Anna S. Aledia, Xiao-Juan Ye, Yun Liu, Yueqin Liu, Xiaolan Zhu, Wenlin Xu, Yuefeng Li and Yanbin Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and PLoS ONE.

In The Last Decade

Xiaofang Chen

61 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofang Chen China 19 614 282 150 147 138 67 1.2k
Hanna Piotrowska‐Kempisty Poland 20 639 1.0× 240 0.9× 112 0.7× 204 1.4× 114 0.8× 79 1.4k
Takao Fukuda Japan 23 990 1.6× 235 0.8× 218 1.5× 223 1.5× 125 0.9× 85 2.0k
Lin Huang China 24 830 1.4× 283 1.0× 119 0.8× 213 1.4× 45 0.3× 74 1.5k
Dandan Wang China 24 982 1.6× 221 0.8× 389 2.6× 74 0.5× 69 0.5× 105 1.7k
Kerstin Reisinger Germany 23 416 0.7× 320 1.1× 186 1.2× 127 0.9× 50 0.4× 37 1.4k
Yanling Lin China 18 415 0.7× 177 0.6× 70 0.5× 110 0.7× 59 0.4× 61 1.0k
Jian Gao China 26 973 1.6× 273 1.0× 254 1.7× 95 0.6× 118 0.9× 97 1.7k
Ioana Ilie Romania 18 509 0.8× 165 0.6× 201 1.3× 265 1.8× 56 0.4× 59 1.4k
Kun Liu China 22 645 1.1× 211 0.7× 104 0.7× 111 0.8× 94 0.7× 71 1.3k
Houman Kahroba Iran 22 987 1.6× 476 1.7× 219 1.5× 144 1.0× 85 0.6× 55 1.6k

Countries citing papers authored by Xiaofang Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaofang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Chen more than expected).

Fields of papers citing papers by Xiaofang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Chen. The network helps show where Xiaofang Chen may publish in the future.

Co-authorship network of co-authors of Xiaofang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Chen. A scholar is included among the top collaborators of Xiaofang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Chen. Xiaofang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaofang, et al.. (2025). A robust and interpretable ensemble machine learning model for predicting healthcare insurance fraud. Scientific Reports. 15(1). 218–218. 3 indexed citations
2.
Wu, Meng, Xiaofang Chen, Haoran Wang, et al.. (2025). Discovery of the Clinical Candidate YY2201 as a Highly Potent and Selective ATR Inhibitor. Journal of Medicinal Chemistry. 68(5). 5292–5311. 4 indexed citations
3.
Chen, Xiaofang, et al.. (2025). Curvature-induced magnetic anisotropy in two-dimensional magnetic semiconductor CrSBr. Applied Physics Letters. 127(5).
4.
Sun, Yuchen, et al.. (2024). Phosphoserine aminotransferase deficiency diagnosed by whole‐exome sequencing and LC–MS/MS reanalysis: A case report and review of literature. Molecular Genetics & Genomic Medicine. 12(4). e2400–e2400. 2 indexed citations
6.
Xu, Wenwen, Feng Tang, Qin Zhou, et al.. (2023). The bacterial effector SidN/Lpg1083 promotes cell death by targeting Lamin-B2. Journal of Molecular Cell Biology. 15(5). 2 indexed citations
7.
Li, Yue, et al.. (2022). Structure-activity relationship and biological evaluation of xanthine derivatives as PCSK9 inhibitors for the treatment of atherosclerosis. European Journal of Medicinal Chemistry. 247. 115047–115047. 6 indexed citations
9.
Zhang, Liang, et al.. (2021). TMEM59 protects against cerebral ischemic stroke by suppressing pyroptosis and microglial activation. Biochemical and Biophysical Research Communications. 543. 72–79. 15 indexed citations
10.
Yin, Hongliang, Guiying Li, Xiaofang Chen, et al.. (2020). Accelerated evolution of bacterial antibiotic resistance through early emerged stress responses driven by photocatalytic oxidation. Applied Catalysis B: Environmental. 269. 118829–118829. 71 indexed citations
11.
Wang, Xuelei, Xiaofang Chen, Xiumin Zhang, et al.. (2020). A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α. EBioMedicine. 52. 102650–102650. 38 indexed citations
12.
Wang, Chenxi, Yanbin Wu, Zhi‐Hong Jiang, et al.. (2020). Design, synthesis, and evaluations of the antiproliferative activity and aqueous solubility of novel carbazole sulfonamide derivatives as antitumor agents. Bioorganic Chemistry. 99. 103766–103766. 18 indexed citations
13.
Na, Li, Ting Wang, Xiaoli Ye, et al.. (2019). Dorsomorphin induces cancer cell apoptosis and sensitizes cancer cells to HSP90 and proteasome inhibitors by reducing nuclear heat shock factor 1 levels. Cancer Biology and Medicine. 16(2). 220–220. 19 indexed citations
14.
Chen, Xiaofang, Shan Liu, Sha Jiang, et al.. (2019). Crystal structure of a hypothetical T2SS effector Lpg0189 from Legionella pneumophila reveals a novel protein fold. Biochemical and Biophysical Research Communications. 521(3). 799–805. 2 indexed citations
15.
Wang, Xichun, Jishun Tang, Lei Zhu, et al.. (2018). Effects of deoxynivalenol exposure on cerebral lipid peroxidation, neurotransmitter and calcium homeostasis of chicks in vivo. Toxicon. 150. 60–65. 20 indexed citations
16.
Chen, Xiaofang, Xinxin Hu, Yanbin Wu, et al.. (2017). Synthesis and in vitro activity of dicationic indolyl diphenyl ethers as novel potent antibiotic agents against drug-resistant bacteria. Bioorganic & Medicinal Chemistry Letters. 27(4). 841–844. 5 indexed citations
18.
Wu, Xianping, Liming Li, Xiaofang Chen, et al.. (2015). [Characteristics of hypertension prevalence and related factors in rural area in Sichuan].. PubMed. 36(11). 1216–9. 5 indexed citations
19.
Chen, Xiaofang, et al.. (2015). Relationship between Serum Bilirubin and Left Ventricular Hypertrophy in Patients with Essential Hypertension. PLoS ONE. 10(4). e0125275–e0125275. 9 indexed citations
20.
Wu, Yanbin, et al.. (2013). Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine. Bioorganic & Medicinal Chemistry Letters. 23(6). 1648–1655. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026